The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia

Sponsor
University of Texas at Austin (Other)
Overall Status
Completed
CT.gov ID
NCT03856606
Collaborator
(none)
8
1
2
4.5
1.8

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the effect of interrupting prolong sedentary behavior with interval exercise on postprandial metabolism following a high fat glucose tolerance test.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Prolonged sitting without exercise
  • Behavioral: Prolonged sitting with interval exercise
N/A

Detailed Description

All subjects complete two trials in a randomized crossover design, with each trial occurring over 4 days with a minimum of seven days between trials. The first two days of each trial serve as a control period allowing for familiarization and the control of physical activity and calorie consumption prior to the intervention. Following each control period, subjects then perform one of the interventions on Day 3. The interventions consist of either eight-hours of prolonged sitting, or eight hours of sitting interrupted every hour by five sprints lasting 4 seconds each using the interval exercise. On day 4, all subjects will undergo a high fat glucose tolerance test to determine the body's ability to clear triglycerides from the blood as well as insulin/glucose response and substrate oxidation. Blood samples will be assayed for the previously mentioned substances and postprandial gas collection will be analyzed via indirect calorimetry.

Study Design

Study Type:
Interventional
Actual Enrollment :
8 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia
Actual Study Start Date :
Feb 20, 2018
Actual Primary Completion Date :
Jul 8, 2018
Actual Study Completion Date :
Jul 8, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Prolonged sitting without exercise

Subjects will be asked to undergo prolonged sitting (~14 hours) of 1 day and will not be asked to perform interval exercise.

Behavioral: Prolonged sitting without exercise
Subjects will have a 2-day control period during which step count and diet will be controlled for and recreated for the other trial. Following this 2-day period, they will undergo the prolonged sitting trial. Day 4 will consist of the lipid tolerance test to determine the ability of the body to clear triglycerides.

Experimental: Prolonged sitting with interval exercise

Subjects will be asked to undergo prolonged sitting (~14 hours) of 1 day and will be asked to perform interval exercise every hour on the hour.

Behavioral: Prolonged sitting with interval exercise
Subjects will have a 2-day control period during which step count and diet will be controlled for and recreated for the other trial. Following this 2-day period, they will undergo a prolonged sit which with will be broken up every hour on the hour by a small bout of interval exercise. Day 4 will consist of the lipid tolerance test to determine the ability of the body to clear triglycerides.

Outcome Measures

Primary Outcome Measures

  1. Plasma Triglycerides [6-hours]

    Areas under the curve for triglyceride concentration will be calculated for hourly samples from a 6-hour lipid tolerance test

Secondary Outcome Measures

  1. Plasma Insulin [6-hours]

    Areas under the curve for insulin concentration will be calculated for hourly samples from a 6-hour lipid tolerance test

  2. Plasma Glucose [6-hours]

    Areas under the curve for glucose concentration will be calculated for hourly samples from a 6-hour lipid tolerance test

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Exclusion Criteria:
  • cardiovascular problems (e.g. pre-existing heart issues, coronary artery disease, hypertension, etc.)

  • respiratory problems

  • musculoskeletal problems that prevent prolonged sitting or exercise

  • susceptibility to fainting

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Texas at Austin Human Performance Laboratory Austin Texas United States 78712

Sponsors and Collaborators

  • University of Texas at Austin

Investigators

  • Study Director: Edward F Coyle, Ph.D., University of Texas at Austin

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Edward F. Coyle, Professor, University of Texas at Austin
ClinicalTrials.gov Identifier:
NCT03856606
Other Study ID Numbers:
  • 2017-11-0141
First Posted:
Feb 27, 2019
Last Update Posted:
Feb 27, 2019
Last Verified:
Feb 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 27, 2019